Position in BIOA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$8,686,221
+$6,033,443 QoQ
Shares Held
354,395
+133.7% QoQ
Ownership
0.772%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#24
of 151 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $47,294,180 across 23 Drug Manufacturers - Specialty & Generic names. BIOA ranks #3 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
165,410 | $11,886,362 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
106,112 | $8,783,951 | |
| 3 | BIOA |
BioAge Labs, Inc.
This page
|
354,395 | $8,686,221 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
611,296 | $4,841,464 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
186,588 | $3,351,120 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
86,249 | $3,122,213 | |
| 7 | EOLS |
Evolus, Inc.
|
253,817 | $1,761,489 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
282,568 | $1,175,482 |
All Filings in BIOA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,686,221 | 354,395 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,652,778 | 151,674 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,783,337 | 134,795 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $75,810 | 12,893 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $63,986 | 15,493 | Shares | Sole | 2025-08-13 | |
| 2024-09-30 | $1,599,000 | 76,875 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||